Navigation Links
'Exercise pill' switches on gene that tells cells to burn fat

By giving ordinary adult mice a drug - a synthetic designed to mimic fat - Salk Institute scientist Dr. Ronald M. Evans is now able to chemically switch on PPAR-d, the master regulator that controls the ability of cells to burn fat. Even when the mice are not active, turning on the chemical switch activates the same fat-burning process that occurs during exercise. The resulting shift in energy balance (calories in, calories burned) makes the mice resistant to weight gain on a high fat diet.

The hope, Dr. Evans told scientists attending Experimental Biology 2007 in Washington, DC, is that such metabolic trickery will lead to a new approach to new treatment and prevention of human metabolic syndrome. Sometimes called syndrome X, this consists of obesity and the often dire health consequences of obesity: high blood pressure, high levels of fat in the blood, heart disease, and resistance to insulin and diabetes.

Dr. Evan’s Experimental Biology presentation on April 30 is part of the scientific program of the American Society for Biochemistry and Molecular Biology.

This chemical switch is not the first success Dr. Evan’s laboratory has had in being able to turn on the PPAR-d switch in adipose or fat cells, activating local metabolism and increasing the amount of calories burned. As a Howard Hughes Medical Investigator at The Salk Institute’s Gene Expression Laboratory, Dr. Evans discovered the role of the gene for PPAR-d, the master regulator of fat metabolism. By permanently turning on this delta switch in mice through genetic engineering, he was able to create a mouse with an innate resistance to weight gain and twice the physical endurance of normal mice. Because they were able to run an hour longer than a normal mouse, they were dubbed "marathon mice."

Subsequent work in the Evans laboratory found that activation of PPAR-d in these mice also suppresses the inflammatory response associated with arthrosclerosis.

But
'"/>

Source:Federation of American Societies for Experimental Biology


Page: 1 2

Related biology news :

1. Switching to new anti-bacterial targets: Riboswitches
2. Nano machine switches between biological and silicon worlds
3. Flick of a protein switches immune response
4. Light-sensitive photoswitches could restore sight to those with macular degeneration
5. Gene therapy research switches off joint inflammation; switches on genetic process of joint repair
6. Beyond the DNA: Chemical signatures reveal genetic switches in the genome
7. Leprosy genome tells story of human migrations, French researchers report in Science
8. Immune systems distress signal tells bacteria when to strike back
9. DNA from feathers tells tale of eagle fidelity
10. Researchers find gland that tells fruit flies when to stop growing
11. Microbiology text tells stories, offers online resources

Post Your Comments:
(Date:11/8/2009)...YETTE, Ind. - Researchers at Purdue University hav...nerve fibers in spinal cord injuries using nano-sp...y after an accident. , The synthetic "copolymer ...eters in diameter, or roughly 100 times smaller th...rs have been studying how to deliver drugs for can...
(Date:11/6/2009)... the 150th anniversary this month of the publicati...tute of Biological Sciences (AIBS) is publishing o...s Darwin and his historic insights into evolution....iversity of California, Berkeley, and James T. Cos...e, "Ten Myths About Charles Darwin," appeared in t...
(Date:11/5/2009)... Association of Biology Teachers (NABT) will recog... sciences at Naugatuck Valley Community College (N...ution Education Award during the NABT annual profe...vember 2009 in Denver, Colorado. , The Evolution...stitute of Biological Sciences,(AIBS) and Biologi...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Biologists, educators recognize excellence in evolution education 2Whooping Cough Immunity Lasts 30 Years or More 60406 1Whooping Cough Immunity Lasts 30 Years or More 60406 2U S President 26apos 3Bs Emergency Plan for AIDS Relief Joins mHealth Alliance 60401 1U S President 26apos 3Bs Emergency Plan for AIDS Relief Joins mHealth Alliance 60401 2U S President 26apos 3Bs Emergency Plan for AIDS Relief Joins mHealth Alliance 60401 3Zeus Increases Its Presence in Aerospace Industry with AS9100 Certification 14665 1Zeus Increases Its Presence in Aerospace Industry with AS9100 Certification 14665 2
...ENO, Nev. The first real-world, demonstration-sca...l has successfully completed the initial stage of ...oject is on track to show the process is an econom...in Nevada. , University researchers have harvest...as part of their collaborative algae-to-biofuels p...
... key phase in the repair process of damaged human ...eam of researchers at the University of California...out the role played by a protein known as Rad51, w...nd critical process. , The breakthrough comes a ...ed professor of microbiology and the study,s princ...
... recent study by researchers at the University of ... that scientists, knowledge of the evolution of di...iologists use two ways to study the evolution of p...dioactive dating techniques to put fossils in chro...in which they are found (stratigraphy); secondly t...
Other Biology News:Success for first outdoor, large-scale algae-to-biofuel research project in Nevada 2Human DNA repair process recorded in action 2Dinosaur fossils fit perfectly into the evolutionary tree of life 2
(Date:11/10/2009)... iSirona Appoints John Cooper as Chairman of... Fla. (PRWEB) November 10, 2009 -- iSirona®, a... for healthcare providers, today announced the app...effective October 21, 2009. He replaces Chairman D... serve as the company,s CEO and retains a seat on ...
(Date:11/9/2009)...Nov. 9 /PRNewswire-Asia-FirstCall/ -- Yongye Inter...Company") a leading manufacturer, developer,and di...trient products in the,People,s Republic of China ...erence call at 10:00 a.m. Eastern Time (11:00 p.m....cuss results for the quarter ended September 30, 2...
(Date:11/9/2009)...Nov. 9 CEL-SCI Corporati...neth S. Rosenthal, Professor of Immunology and Mic...e of Medicine and Pharmacy, reported on work condu...land Clinic and CEL-SCI on CEL-SCI,s LEAPS vaccine...Cbio Vaccine: "All Things Considered" Conference i...
(Date:11/8/2009)...IEW, Calif. Nov. 5, 2009 Complete Genomics, a th...day announced publication of a report in the journ...cing platform, including analysis of sequence data...s cost for these three genomes sequenced on the pr...m $8,005 for 87x coverage to $1,726 for 45x covera...
Breaking Biology Technology:iSirona Selects New Chairman of the Board 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 2Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results 3CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 2CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 3Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2
...Laboratories,Holdings, Ltd., a wholly owned subsid...nnounced today that it and Mylan Inc. (NYSE: MYL ...mercialize, develop and,distribute the novel beta ...ly approved in the United States for the treatment...orest will assume Mylan,s commercial rights,for By...
...accinogen, Inc. announced that,its new vaccine to ...ally,available in Europe starting June 2008., "Th... viable vaccine,for colon cancer," said Dr. Michae...en. "It is the beginning of our worldwide strategy...ibility of patient specific anti-cancer,therapies ...
...Pharmasset, Inc.,(Nasdaq: VRUS ) management will ...nual SIGnificant Investment Options in Healthcare ...el in New York, NY. Schaefer Price,Pharmasset,s Ch... the,company on Wednesday, March 5, 2008 from 2:00...m. In addition, Dr. Michelle Berrey, Pharmasset,s,...
Other Biology Technology:Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement 2Forest Laboratories, Inc. Announces Amendment to Bystolic(TM) (nebivolol) Agreement 3Vaccinogen's New Anti-Cancer Vaccine Commercially Available in Europe This Year 2Pharmasset to Present at Susquehanna's Second Annual SIGnificant Investment Options in Healthcare Conference on Wednesday, March 5th 2
...a;-1, clone C464.6 GenBank Accession Number : NM_...isolated from membrane fractions of rabbit kidney ....4, 0.15M NaCl containing 0.05% sodium azide Quali... rat brain microsomal preparations Recognizes &alp...
Mouse Anti-Human PSGL-1 Monoclonal Antibody, Unconjugated, Clone 215 from Santa Cruz Biotechnology, Inc.
Mouse Anti-Adenovirus Type 7 hexon C11 Monoclonal Antibody, Unconjugated, Clone 1-N-14 from GeneTex
Mouse Anti-20S proteasome subunits alpha 1 Monoclonal Antibody, Unconjugated, Clone MCP231 from Upstate
Biology Products: